These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23868145)

  • 1. Obesity-related glomerulopathy and the nephron complement.
    Tsuboi N; Utsunomiya Y; Hosoya T
    Nephrol Dial Transplant; 2013 Nov; 28 Suppl 4():iv108-13. PubMed ID: 23868145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity-related glomerulopathy: pathogenesis, pathologic, clinical characteristics and treatment.
    Xu T; Sheng Z; Yao L
    Front Med; 2017 Sep; 11(3):340-348. PubMed ID: 28791668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Renal Pathology of Obesity: Structure-Function Correlations.
    Tsuboi N; Okabayashi Y
    Semin Nephrol; 2021 Jul; 41(4):296-306. PubMed ID: 34715960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular sclerosis in patients with massive obesity.
    Kasiske BL; Napier J
    Am J Nephrol; 1985; 5(1):45-50. PubMed ID: 3970078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity-Related Glomerulopathy: A Latent Change in Obesity Requiring More Attention.
    Yang S; Cao C; Deng T; Zhou Z
    Kidney Blood Press Res; 2020; 45(4):510-522. PubMed ID: 32498064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological characteristics of obesity-associated focal segmental glomerulosclerosis.
    Darouich S; Goucha R; Jaafoura MH; Zekri S; Ben Maiz H; Kheder A
    Ultrastruct Pathol; 2011 Aug; 35(4):176-82. PubMed ID: 21657818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low glomerular density with glomerulomegaly in obesity-related glomerulopathy.
    Tsuboi N; Utsunomiya Y; Kanzaki G; Koike K; Ikegami M; Kawamura T; Hosoya T
    Clin J Am Soc Nephrol; 2012 May; 7(5):735-41. PubMed ID: 22403274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity-related glomerulopathy: an emerging epidemic.
    Kambham N; Markowitz GS; Valeri AM; Lin J; D'Agati VD
    Kidney Int; 2001 Apr; 59(4):1498-509. PubMed ID: 11260414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Fatty Kidney: Obesity and Renal Disease.
    Praga M; Morales E
    Nephron; 2017; 136(4):273-276. PubMed ID: 27414023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From segmental glomerulosclerosis to total nephron degeneration and interstitial fibrosis: a histopathological study in rat models and human glomerulopathies.
    Kriz W; Hosser H; Hähnel B; Gretz N; Provoost AP
    Nephrol Dial Transplant; 1998 Nov; 13(11):2781-98. PubMed ID: 9829480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The kidney failure of Bourneville's tuberous sclerosis: a new form of glomerular damage as a result of hyperfiltration?].
    Schillinger F; Montagnac R; Grapin JL; Birembaut P; Hopfner C
    Nephrologie; 1985; 6(5):219-23. PubMed ID: 4094635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal glomerulosclerosis in obese zucker rats and prevention of its development.
    Shimamura T
    Kidney Int Suppl; 1983 Dec; 16():S259-62. PubMed ID: 6588262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary focal segmental glomerulosclerosis in non-obese patients with increased muscle mass.
    Schwimmer JA; Markowitz GS; Valeri AM; Imbriano LJ; Alvis R; D'Agati VD
    Clin Nephrol; 2003 Oct; 60(4):233-41. PubMed ID: 14579937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive renal failure--inability of podocytes to replicate and the consequences for development of glomerulosclerosis.
    Kriz W
    Nephrol Dial Transplant; 1996 Sep; 11(9):1738-42. PubMed ID: 8918614
    [No Abstract]   [Full Text] [Related]  

  • 15. Pathways to nephron loss starting from glomerular diseases-insights from animal models.
    Kriz W; LeHir M
    Kidney Int; 2005 Feb; 67(2):404-19. PubMed ID: 15673288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which Patients with Obesity Are at Risk for Renal Disease?
    Sandino J; Luzardo L; Morales E; Praga M
    Nephron; 2021; 145(6):595-603. PubMed ID: 33677441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal sclerosis of hypertrophied glomeruli in solitary functioning kidneys of humans.
    Bhathena DB; Julian BA; McMorrow RG; Baehler RW
    Am J Kidney Dis; 1985 May; 5(5):226-32. PubMed ID: 4003392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis.
    D'Agati VD; Chagnac A; de Vries AP; Levi M; Porrini E; Herman-Edelstein M; Praga M
    Nat Rev Nephrol; 2016 Aug; 12(8):453-71. PubMed ID: 27263398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards a definition of glomerulomegaly: clinical-pathological and methodological considerations.
    Hughson MD; Hoy WE; Douglas-Denton RN; Zimanyi MA; Bertram JF
    Nephrol Dial Transplant; 2011 Jul; 26(7):2202-8. PubMed ID: 21115671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies for pronounced susceptibility of deep nephrons to glomerular sclerosis in young animals.
    Fogo A; Ikoma M; Yoshida Y; Ichikawa I
    Contrib Nephrol; 1991; 95():126-30. PubMed ID: 1807904
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.